Recently approved by the FDA, Ozempic sets itself apart from other once-weekly GLP-1 RAs for type 2 diabetes by demonstrating the quickest and greatest effect in reducing blood glucose and body weight in studies. Is it right for you?
[read_more text="read more" title="read more" url="https://tcoyd.org/2018/03/https-tcoyd-org-2018-03-ozempic/" align="left"]